Aspirin therapy was associated with decreased rates of hepatocellular carcinoma among people with chronic hepatitis B without cirrhosis, researchers reported at The Liver Meeting Digital Experience.
Aspirin tied to lower risk of hepatocellular carcinoma
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.